1. A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies. Issue 2 (19th June 2020) Authors: Monnier, Annelie A; Tacconelli, Evelina; Årdal, Christine; Cavaleri, Marco; Gyssens, Inge C Journal: JAC-antimicrobial resistance Issue: Volume 2:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. Issue 45 (29th October 2021) Authors: Moore, Kristine A.; Ostrowsky, Julia T.; Kraigsley, Alison M.; Mehr, Angela J.; Bresee, Joseph S.; Friede, Martin H.; Gellin, Bruce G.; Golding, Josephine P.; Hart, Peter J.; Moen, Ann; Weller, Charlotte L.; Osterholm, Michael T.; Ampofo, William; Barclay, Wendy; Cavaleri, Marco; Cohen, Cheryl; C... Journal: Vaccine Issue: Volume 39:Issue 45(2021) Page Start: 6573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola. (February 2016) Authors: Cavaleri, Marco; Thomson, Andrew; Salmonson, Tomas; Hemmings, Robert J Journal: Clinical trials Issue: Volume 13:Number 1(2016) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Approaches to demonstration of Ebola virus vaccine efficacy. Issue 6 (June 2015) Authors: Krause, Philip R; Cavaleri, Marco; Coleman, Gina; Gruber, Marion F Journal: Lancet infectious diseases Issue: Volume 15:Issue 6(2015:Jun.) Page Start: 627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Attention for sex in COVID-19 trials: a review of regulatory dossiers. Issue 3 (18th March 2022) Authors: de Vries, Sieta T; Starokozhko, Viktoriia; Schellens, Ingrid M M; Wijnans, Leonoor; Enzmann, Harald; Cavaleri, Marco; Mol, Peter G M Journal: BMJ global health Issue: Volume 7:Issue 3(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case. Issue 12 (15th March 2022) Authors: Kochhar, Sonali; Barreira, Draurio; Beattie, Pauline; Cavaleri, Marco; Cravioto, Alejandro; Frick, Mike W.; Ginsberg, Ann M.; Hudson, Ian; Kaslow, David C.; Kurtz, Sherry; Lienhardt, Christian; Madhi, Shabir A.; Morgan, Christopher; Momeni, Yalda; Patel, Deepali; Rees, Helen; Rogalski-Salter, Tar... Journal: Vaccine Issue: Volume 40:Issue 12(2022) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines. Issue 24 (7th June 2018) Authors: Vannice, Kirsten S.; Wilder-Smith, Annelies; Barrett, Alan D.T.; Carrijo, Kalinka; Cavaleri, Marco; de Silva, Aravinda; Durbin, Anna P.; Endy, Tim; Harris, Eva; Innis, Bruce L.; Katzelnick, Leah C.; Smith, Peter G.; Sun, Wellington; Thomas, Stephen J.; Hombach, Joachim Journal: Vaccine Issue: Volume 36:Issue 24(2018) Page Start: 3411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Clinical Trials for COVID‐19: Can we Better Use the Short Window of Opportunity?. Issue 4 (12th June 2020) Authors: Eichler, Hans‐Georg; Cavaleri, Marco; Enzmann, Harald; Scotti, Francesca; Sepodes, Bruno; Sweeney, Fergus; Vamvakas, Spiros; Rasi, Guido Journal: Clinical pharmacology & therapeutics Issue: Volume 108:Issue 4(2020) Page Start: 730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates. Issue 6 (4th February 2019) Authors: Vannice, Kirsten S.; Cassetti, M. Cristina; Eisinger, Robert W.; Hombach, Joachim; Knezevic, Ivana; Marston, Hilary D.; Wilder-Smith, Annelies; Cavaleri, Marco; Krause, Philip R. Journal: Vaccine Issue: Volume 37:Issue 6(2019) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Issue 3 (March 2018) Authors: Tacconelli, Evelina; Carrara, Elena; Savoldi, Alessia; Harbarth, Stephan; Mendelson, Marc; Monnet, Dominique L; Pulcini, Céline; Kahlmeter, Gunnar; Kluytmans, Jan; Carmeli, Yehuda; Ouellette, Marc; Outterson, Kevin; Patel, Jean; Cavaleri, Marco; Cox, Edward M; Houchens, Chris R; Grayson, M Lindsa... Journal: Lancet infectious diseases Issue: Volume 18:Issue 3(2018) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗